CTXR logo

Citius Pharmaceuticals, Inc.

CTXR
Healthcare|Biotechnology|US
$0.55
-0.01 (-2.21%)
DCF Value
$0.92
Cash / Share
$0.65
Next Earnings Report
Dec 22, 2026
EPS est. -$0.41 · Revenue est. $2.9M
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest May 22, 2026 (S-3). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Citius Oncology's Positive Quality of Life Data for LYMPHIR® (denileukin diftitox-cxdl) in Relapsed or Refractory Cutaneous T-Cell Lymphoma Presented at Premier Global CLTG Congress in Europe
Nov 4, 2026 · PRNewsWire
Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026
Oct 26, 2026 · PRNewsWire
Citius Pharmaceuticals to Participate in October 2026 Investor Conferences
Oct 12, 2026 · PRNewsWire
Citius Pharmaceuticals to Participate in September 2026 Investor Conferences
Sep 3, 2026 · PRNewsWire
Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Aug 14, 2026 · PRNewsWire
Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Aug 14, 2026 · PRNewsWire
Citius Oncology Expands Board with Appointment of Independent Director Jonathan Peri
Aug 12, 2026 · PRNewsWire

SEC Filings (76)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 4, 20268-KMaterial eventDocumentIndex
Oct 26, 20268-KMaterial eventDocumentIndex
Aug 21, 20268-KMaterial eventDocumentIndex
Aug 14, 202610-QQuarterly reportDocumentIndex
Aug 14, 20268-KMaterial eventDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 5, 20268-KMaterial eventDocumentIndex
Jun 4, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jun 2, 2026EFFECTDocumentIndex
Jun 1, 20268-KMaterial eventDocumentIndex
May 22, 2026S-3Shelf registrationDocumentIndex
May 15, 20268-KMaterial eventDocumentIndex
May 15, 202610-QQuarterly reportDocumentIndex
May 8, 20268-KMaterial eventDocumentIndex
Apr 29, 20268-KMaterial eventDocumentIndex
Apr 24, 20268-KMaterial eventDocumentIndex
Apr 24, 2026424B5Offering prospectusDocumentIndex
Apr 6, 20268-KMaterial eventDocumentIndex
Mar 31, 20268-KMaterial eventDocumentIndex
Mar 10, 20268-KMaterial eventDocumentIndex
Mar 4, 20268-KMaterial eventDocumentIndex
Feb 24, 2026ARSAnnual report to holdersDocumentIndex
Feb 24, 2026DEFA14AProxy / shareholder voteDocumentIndex
Feb 24, 2026DEF 14AProxy / shareholder voteDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 13, 20268-KMaterial eventDocumentIndex
Feb 13, 202610-QQuarterly reportDocumentIndex
Jan 28, 202610-K/AAnnual reportDocumentIndex
Dec 23, 20258-KMaterial eventDocumentIndex
Dec 23, 202510-KAnnual reportDocumentIndex
Dec 17, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Dec 1, 20258-KMaterial eventDocumentIndex
Oct 27, 2025SC 13GPassive 5%+ stakeDocumentIndex
Oct 23, 20258-KMaterial eventDocumentIndex
Oct 21, 20258-KMaterial eventDocumentIndex
Oct 21, 2025424B5Offering prospectusDocumentIndex
Sep 12, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Aug 12, 20258-KMaterial eventDocumentIndex
Aug 12, 202510-QQuarterly reportDocumentIndex
Jul 25, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex